{"id":"2e45c303-f371-4bb7-8aed-68a00fc7add0","modelId":"e78dd2d7-d5e9-4c79-b52a-387ea5adf073","versionId":null,"locationId":"15016394-5d51-4c5f-8cbf-329374a3e217","operatorId":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","ownerId":null,"slug":"remebot-rm-50-beijing","status":"operational","firstSeen":"2022-01-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"unreviewed","sources":[{"url":"https://www.chinadaily.com.cn/a/202208/18/WS62fe01e2a310fd2b29e73066.html","title":"Medical robots improve quality of life","sourceName":"China Daily","publishedAt":"2022-08-18"}],"notes":"RM-50 cerebral hemorrhage robot certified at over 100 domestic hospitals, used in over 30,000 surgeries. NMPA certified 2022. Showcased at 2022 World Robot Conference in Beijing.","keyFacts":[{"label":"Hospitals","value":"Over 100 domestic hospitals certified (company-reported)"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-04T01:05:07.876Z","updatedAt":"2026-08-04T01:05:07.876Z","model":{"id":"e78dd2d7-d5e9-4c79-b52a-387ea5adf073","companyId":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","modelName":"RM-50","slug":"remebot-rm-50","description":"The RM-50 is Remebot's cerebral hemorrhage surgical robot, featuring a 1-meter-tall frame with a robotic arm for minimally invasive neurosurgical procedures. It constructs 3D models of the brain to guide hematoma drainage through a 1mm-diameter hole. Received NMPA certification in 2022 and has been deployed at over 100 hospitals","formFactor":"surgical","industryVertical":null,"environment":null,"maturityStage":"production","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"unreviewed","sources":[{"url":"https://www.chinadaily.com.cn/a/202208/18/WS62fe01e2a310fd2b29e73066.html","label":"Medical robots improve quality of life","title":"Medical robots improve quality of life","mediaType":"article","sourceName":"China Daily"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[],"createdAt":"2026-08-04T01:04:19.182Z","updatedAt":"2026-08-04T01:04:19.182Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","name":"Remebot","slug":"remebot","description":"Remebot is a Chinese surgical robotics company (Beijing Baihui Weikang Technology Co., Ltd. / 柏惠维康) developing neurosurgical and dental robots for stereotactic procedures. Spun out of Beihang University research led by Wang Tianmiao, the Remebot system became China's first NMPA-approved neurosurgical robot in 2018. Its RM-50 cerebral hemorrhage robot and dental robot have been deployed across 300+ hospitals in 31 provinces, performing over 30,000 clinical operations","status":"active","founded":2010,"hq":"Beijing, China","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.remebot.com.cn/","title":"Remebot","date_accessed":"2026-06-27"}],"keyFacts":[{"label":"Robot","value":"Remebot, China's first domestic neurosurgical robot"},{"label":"Regulatory","value":"NMPA-approved in 2018"},{"label":"Applications","value":"Used for biopsy, hematoma drainage, and deep-brain-stimulation procedures"},{"label":"Product","value":"Also produces a dental implant robot"},{"label":"Company","value":"Operated by Beijing Baihui Weikang Technology"},{"label":"CEO","value":"Da Liu (刘达)"},{"label":"Founder","value":"Da Liu (刘达), Beihang University spin-out"},{"label":"Research lead","value":"Wang Tianmiao (王田苗), honorary director of Robotics Institute at Beihang University"},{"label":"NMPA approvals","value":"2018 (neurosurgery Class III — first in China), 2021 (oral surgery — first in China), 2022 (RM-50 cerebral hemorrhage)"},{"label":"Cumulative funding","value":"~USD 84.6M (4 rounds per CB Insights; company reports 430M RMB Series D, 600M RMB cumulative)"},{"label":"Clinical operations","value":"Over 30,000 clinical operations across 300+ hospitals in 31 provinces (company-reported)"},{"label":"Products","value":"Remebot Surgical Robot, Remebot Dental Robot, RM-50 cerebral hemorrhage robot"},{"label":"Precision","value":"0.5mm positioning precision with independent optical navigation system"}],"aliases":["Beijing Baihui Weikang Technology","Baihui Weikang"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-27T12:15:40.963Z","updatedAt":"2026-08-04T01:03:02.364Z"}},"version":null,"location":{"id":"15016394-5d51-4c5f-8cbf-329374a3e217","name":"Beijing, China","slug":"beijing-beijing-china","kind":"city","parentLocationId":null,"region":null,"lat":null,"lng":null,"reviewStatus":"unreviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-04T01:05:05.552Z","updatedAt":"2026-08-04T01:05:05.552Z"},"operator":{"id":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","name":"Remebot","slug":"remebot","description":"Remebot is a Chinese surgical robotics company (Beijing Baihui Weikang Technology Co., Ltd. / 柏惠维康) developing neurosurgical and dental robots for stereotactic procedures. Spun out of Beihang University research led by Wang Tianmiao, the Remebot system became China's first NMPA-approved neurosurgical robot in 2018. Its RM-50 cerebral hemorrhage robot and dental robot have been deployed across 300+ hospitals in 31 provinces, performing over 30,000 clinical operations","status":"active","founded":2010,"hq":"Beijing, China","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.remebot.com.cn/","title":"Remebot","date_accessed":"2026-06-27"}],"keyFacts":[{"label":"Robot","value":"Remebot, China's first domestic neurosurgical robot"},{"label":"Regulatory","value":"NMPA-approved in 2018"},{"label":"Applications","value":"Used for biopsy, hematoma drainage, and deep-brain-stimulation procedures"},{"label":"Product","value":"Also produces a dental implant robot"},{"label":"Company","value":"Operated by Beijing Baihui Weikang Technology"},{"label":"CEO","value":"Da Liu (刘达)"},{"label":"Founder","value":"Da Liu (刘达), Beihang University spin-out"},{"label":"Research lead","value":"Wang Tianmiao (王田苗), honorary director of Robotics Institute at Beihang University"},{"label":"NMPA approvals","value":"2018 (neurosurgery Class III — first in China), 2021 (oral surgery — first in China), 2022 (RM-50 cerebral hemorrhage)"},{"label":"Cumulative funding","value":"~USD 84.6M (4 rounds per CB Insights; company reports 430M RMB Series D, 600M RMB cumulative)"},{"label":"Clinical operations","value":"Over 30,000 clinical operations across 300+ hospitals in 31 provinces (company-reported)"},{"label":"Products","value":"Remebot Surgical Robot, Remebot Dental Robot, RM-50 cerebral hemorrhage robot"},{"label":"Precision","value":"0.5mm positioning precision with independent optical navigation system"}],"aliases":["Beijing Baihui Weikang Technology","Baihui Weikang"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-27T12:15:40.963Z","updatedAt":"2026-08-04T01:03:02.364Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/remebot-rm-50-beijing","url":"https://registry.deploy.report/deployments/remebot-rm-50-beijing","name":"RM-50 at Beijing, China","identifier":"2e45c303-f371-4bb7-8aed-68a00fc7add0","startDate":"2022-01-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/beijing-beijing-china","name":"Beijing, China"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/remebot","name":"Remebot"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/remebot-rm-50","name":"RM-50"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"unreviewed","maturity_stage":"production","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}